{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:54:40Z","timestamp":1782917680618,"version":"3.54.5"},"reference-count":25,"publisher":"Scientific Scholar","content-domain":{"domain":["ijmr.org.in"],"crossmark-restriction":true},"short-container-title":["Indian J Med Res"],"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>This systematic review seeks to assess the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with type 2 diabetes mellitus (T2DM) within the Indian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search of SCOPUS, Web of Science and PubMed was performed for studies published from January 2000 to March 2025, using search terms such as MASLD, T2DM, NAFLD, steatohepatitis and India. This systematic review considered eligible Indian studies that included patients (\u226518 years old) with T2DM and reported the prevalence of MASLD\/NAFLD. The study excluded reviews, case reports, conference abstracts, editorials, and studies that did not have full texts. Pooled MASLD prevalence determined by liver biopsy, transient elastography, ultrasound, or biochemical markers was the main result. Prevalence estimates were combined using a random-effects model, and quality was evaluated using the Joanna Briggs Institute approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across the 18 selected studies, the pooled prevalence of MASLD was estimated from 81,364 adult diabetic participants. In diabetic adults, the estimated pooled prevalence of MASLD was 56.9% [95% Confidence interval (CI), 39.1\u201374.8]. Among these studies, the prevalence by biochemical marker was 50.4% (95% CI 38.6 \u2013 62.2), the prevalence by ultrasonography was 55.6% (95% CI 37.1 \u2013 74.1), and the prevalence by Fibroscan as an imaging modality was 64.3% (95% CI 31 \u2013 97.7). Several limitations were noted; many studies provided insufficient information regarding cohort representativeness, selection criteria for non-exposed groups, and the adequacy of follow up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation and conclusions<\/jats:title>\n                    <jats:p>While awareness of MASLD is increasing among diabetic populations globally, data concerning its prevalence and clinical characteristics in the Indian population\u2014especially within regional demographics\u2014remains limited. The variability in reported prevalence rates, ranging from 34 to 94%, among individuals with T2DM indicates a pressing need for region-specific research that considers the diverse ethnic backgrounds, diets, and lifestyles throughout India.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/ijmr_2480_2025","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:25:47Z","timestamp":1782908747000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of metabolic dysfunction associated steatotic liver disease in type 2 diabetes mellitus in India: A systematic review and meta-analysis"],"prefix":"10.25259","volume":"164","author":[{"given":"Abhishek","family":"Singhai","sequence":"first","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Meena","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Khadanga","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratinder","family":"Jhaj","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpesh","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Wakode","sequence":"additional","affiliation":[{"name":"Department of Physiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"10.25259\/IJMR_2480_2025\/ref-1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology."},{"key":"10.25259\/IJMR_2480_2025\/ref-2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol."},{"key":"10.25259\/IJMR_2480_2025\/ref-3","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J Lipid Res."},{"key":"10.25259\/IJMR_2480_2025\/ref-4","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.2147\/DMSO.S520806","article-title":"High prevalence of fatty liver in Bangladeshi adolescents and young adults with type 2 diabetes: Key Predictors and Screening Recommendations","volume":"18","author":"Shil","year":"2025","journal-title":"Diabetes Metab Syndr Obes."},{"key":"10.25259\/IJMR_2480_2025\/ref-5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"10.25259\/IJMR_2480_2025\/ref-6","first-page":"243","article-title":"A study of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus in a tertiary care centre, Southern India","volume":"6","author":"Jayarama","year":"2012","journal-title":"J Clin of Diagn Res."},{"key":"10.25259\/IJMR_2480_2025\/ref-7","first-page":"351","article-title":"Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes","volume":"59","author":"Agarwal","year":"2011","journal-title":"J Assoc Physicians India."},{"key":"10.25259\/IJMR_2480_2025\/ref-8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.dsx.2018.01.001","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease","volume":"12","author":"Vanjiappan","year":"2018","journal-title":"Diabetes Metab Syndr."},{"key":"10.25259\/IJMR_2480_2025\/ref-9","first-page":"205","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"57","author":"Prashanth","year":"2009","journal-title":"J Assoc Physicians India."},{"key":"10.25259\/IJMR_2480_2025\/ref-10","first-page":"448","article-title":"Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)","volume":"61","author":"Kalra","year":"2013","journal-title":"J Assoc Physicians India."},{"key":"10.25259\/IJMR_2480_2025\/ref-11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.diabres.2008.11.039","article-title":"Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome","volume":"84","author":"Mohan","year":"2009","journal-title":"Diabetes Res Clin Pract."},{"key":"10.25259\/IJMR_2480_2025\/ref-12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/0971-9903.202001","article-title":"Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus and its relation with insulin resistance in South Gujarat region","volume":"22","author":"Bhatt","year":"2017","journal-title":"Journal of Mahatma Gandhi Insitute of Medical Sciences."},{"key":"10.25259\/IJMR_2480_2025\/ref-13","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.dsx.2016.01.034","article-title":"Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes","volume":"10","author":"Krishan","year":"2016","journal-title":"Diabetes Metab Syndr."},{"key":"10.25259\/IJMR_2480_2025\/ref-14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.59556\/japi.72.0582","article-title":"Prevalence and association of risk factors according to liver steatosis and fibrosis stages among nonalcoholic fatty liver disease patients with type 2 diabetes mellitus in India: A cross-sectional study","volume":"72","author":"Panikar","year":"2024","journal-title":"J Assoc Physicians India."},{"key":"10.25259\/IJMR_2480_2025\/ref-15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.21276\/ajm.2019.2.2.52","article-title":"To study the occurrence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes Mellitus","volume":"2","author":"Arya","year":"2019","journal-title":"Acad J Med."},{"key":"10.25259\/IJMR_2480_2025\/ref-16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1440-1746.2004.03312.x","article-title":"Non-alcoholic steatohepatitis in type 2 diabetes mellitus","volume":"19","author":"Gupte","year":"2004","journal-title":"J Gastroenterol Hepatol."},{"key":"10.25259\/IJMR_2480_2025\/ref-17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5005\/japi-11001-0065","article-title":"Assessment of prevalence and associated risk factors of NAFLD in people living with diabetes in India: A retrospective, multicenter, electronic medical records based study","volume":"70","author":"Kalra","year":"2022","journal-title":"J Assoc Physicians India."},{"key":"10.25259\/IJMR_2480_2025\/ref-18","first-page":"593","article-title":"Clinicopathological profile of hepatic involvement in type-2 diabetes mellitus and its significance","volume":"56","author":"Banerjee","year":"2008","journal-title":"J Assoc Physicians India."},{"key":"10.25259\/IJMR_2480_2025\/ref-19","first-page":"755","article-title":"Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NRFLD), in recently detected untreated, IGT and type 2 diabetes Indian subjects","volume":"107","author":"Sanyal","year":"2009","journal-title":"J Indian Med Assoc."},{"key":"10.25259\/IJMR_2480_2025\/ref-20","doi-asserted-by":"publisher","first-page":"100161","DOI":"10.1016\/j.deman.2023.100161","article-title":"Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India","volume":"12","author":"Sinha","year":"2023","journal-title":"Diabetes Epidemiol Manag."},{"key":"10.25259\/IJMR_2480_2025\/ref-21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jceh.2021.07.001","article-title":"Diabetes mellitus increases the risk of significant hepatic fibrosis in patients with non-alcoholic fatty liver disease","volume":"12","author":"Chhabra","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"10.25259\/IJMR_2480_2025\/ref-22","doi-asserted-by":"publisher","first-page":"102261","DOI":"10.1016\/j.dsx.2021.102261","article-title":"Retrospective analysis (2009-2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India","volume":"15","author":"Kamalraj","year":"2021","journal-title":"Diabetes Metab Syndr."},{"key":"10.25259\/IJMR_2480_2025\/ref-23","doi-asserted-by":"publisher","DOI":"10.21276\/ijcmsr.2020.5.1.53","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with diabetic nephropathy in type 2 diabetes mellitus patients","volume":"5","author":"Kumar","year":"2020","journal-title":"IJCMSR."},{"key":"10.25259\/IJMR_2480_2025\/ref-24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s13300-025-01748-1","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease: Mapping across different Indian populations (MAP Study)","volume":"16","author":"Mohan","year":"2025","journal-title":"Diabetes Ther."},{"key":"10.25259\/IJMR_2480_2025\/ref-25","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.jceh.2023.08.007","article-title":"Research on non-alcoholic fatty liver disease from Indian subcontinent: A bibliometric analysis of publications during 2001-2022","volume":"14","author":"Vaishya","year":"2024","journal-title":"J Clin Exp Hepatol."}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ijmr.org.in\/prevalence-of-metabolic-dysfunction-associated-steatotic-liver-disease-in-type-2-diabetes-mellitus-in-india-a-systematic-review-and-meta-analysis\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ijmr.org.in\/prevalence-of-metabolic-dysfunction-associated-steatotic-liver-disease-in-type-2-diabetes-mellitus-in-india-a-systematic-review-and-meta-analysis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:19:51Z","timestamp":1782915591000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijmr.org.in\/prevalence-of-metabolic-dysfunction-associated-steatotic-liver-disease-in-type-2-diabetes-mellitus-in-india-a-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":25,"alternative-id":["10.25259\/IJMR_2480_2025"],"URL":"https:\/\/doi.org\/10.25259\/ijmr_2480_2025","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"72"}}